loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: NCGC00024964-02

    Client Email Product
    Menu

    NCGC00024964-02

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 49,217Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 21344 / DOSAGE - SOLUTION;INTRAMUSCULAR - 250MG/5ML (50MG/ML)

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    FULVESTRANT(UNII: 22X328QOC4)
    (FULVESTRANT - UNII:22X328QOC4)     		FULVESTRANT50mg in 1

    Inactive Ingredients

    Ingredient Name
    Accord Healthcare Inc.
    AstraZeneca Pharmaceuticals LP
    BluePoint Laboratories
    EBEWE Pharma Ges.m.b.H. Nfg.KG
    GLENMARK PHARMACEUTICALS INC., USA
    HBT Labs, Inc.
    Hikma Pharmaceuticals USA Inc.
    Mylan Institutional LLC
    Northstar RxLLC
    Sagent Pharmaceuticals
    Zydus Pharmaceuticals USA Inc.
    ALCOHOL(3K9958V90M)
    benzyl alcohol(LKG8494WBH)
    BENZYL BENZOATE(N863NB338G)
    CASTOR OIL(D5340Y2I9G)